TotalMarketCap

Aclaris Therapeutics

ACRSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$529.916 M

$3.60 -2.17%

Close of 6 Nov 2026

As of 6 Nov 2026, Aclaris Therapeutics (ACRS) has a market capitalization of $529.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$7.83M

#3179 by revenue

Earnings

-$64.9M

Loss-making

Shares outstanding

158,612,149

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #181Arbutus BiopharmaABUS$561.8M
  2. #182Bicara TherapeuticsBCAX$542.6M
  3. #183Aclaris TherapeuticsACRS$529.9M
  4. #184NeurogeneNGNE$516.1M
  5. #185Climb BioCLYM$510.0M

What if Aclaris Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$191,828.03

Per share 53,286× higher

Bitcoin $1.53T

$10,379.48

Per share 2,883× higher

Apple $5.02T

$34,074.87

Per share 9,465× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Aclaris Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.